Search

Chun Liu

from Carrboro, NC
Get Report
Related to:
Angela Sing Liu, 37Angela Sing Liu, 37Angela S Santoscortez, 40Liu Sut, 58
Connected to:
Adela Liu, 73Alec X Liu, 39Alpha T Liu, 46Amon Y Liu, 58Andrea Y Liu, 46Anqi Liu, 39Arden K Liu, 64Ba S Liu, 62Bailu Liu, 35Ban Liu, 48

Chun Liu Phones & Addresses

  • Chapel Hill, NC
  • Carrboro, NC

Professional Records

License Records

Chun Nan Liu

License #:
061012061
Issued Date:
Jul 30, 1974
Type:
Enrolled Professional Engineer Intern

Medicine Doctors

Chun Liu Photo 1

Chun Hua Liu

View page
Specialties:
Obstetrics & Gynecology
Work:
Kaiser Permanente Medical GroupKaiser Permanente Medical Center
39400 Paseo Padre Pkwy, Fremont, CA 94538
(510) 248-3000 (phone), (510) 248-3364 (fax)
Education:
Medical School
University of Vermont COM
Graduated: 2002
Procedures:
Tubal Surgery
Vaginal Delivery
Conditions:
Abnormal Vaginal Bleeding
Breast Disorders
Candidiasis of Vulva and Vagina
Conditions of Pregnancy and Delivery
Pelvic Inflammatory Disease (PID)
Languages:
English
Description:
Dr. Liu graduated from the University of Vermont COM in 2002. She works in Fremont, CA and specializes in Obstetrics & Gynecology.

Publications

Us Patents

Chemical Compounds

View page
US Patent:
20220242886, Aug 4, 2022
Filed:
Feb 1, 2022
Appl. No.:
17/590407
Inventors:
- Nashville TN, US
Chunliang LIU - Cary NC, US
Yong-Kang ZHANG - San Jose CA, US
Marissa AUBREY - Durham NC, US
Chun Yu LIU - Durham NC, US
International Classification:
C07F 5/02
Abstract:
The present invention describes novel compounds, or their pharmaceutically acceptable salts, pharmaceutical compositions containing them, and their medical uses. The compounds of the invention have activity as Janus kinase (JAK) inhibitors and are useful in the in the treatment or control of inflammation, auto-immune diseases, cancer, and other disorders and indications where modulation of JAK would be desirable. Also described herein are methods of treating inflammation, auto-immune diseases, cancer, and other conditions susceptible to inhibition of JAK by administering a compound herein described.

Boron-Containing Small Molecules For Inhibiting Activity Of A Receptor-Like Protein Tyrosine Phosphatase

View page
US Patent:
20210052614, Feb 25, 2021
Filed:
Nov 3, 2020
Appl. No.:
17/087962
Inventors:
- University Park PA, US
- Cold Spring Harbor NY, US
Chun Yu Liu - Cary NC, US
Chunliang Liu - Bellefonte PA, US
International Classification:
A61K 31/69
C07F 5/02
Abstract:
A method is disclosed for altering the redox equilibrium of a transmembrane receptor-like protein tyrosine phosphatase (RPTP), particularly a type IIa RPTP, by chemically modulating the activity through contact of such an enzyme with a diaryl boron compound that preferentially reacts with an RPTP in an oxidized state (CyS-OH). This redox modulation is most readily observed and put to use by assaying the inhibition of the phosphatase activity of the RPTP. Such an assay can be carried out on an enzyme in vitro or by contacting the enzyme in a living organism (in vivo). A useful diaryl boron compound corresponds in structure to Formula I in which Ar-1,Ar-2, R, R, Rand Rare defined within. A pharmaceutical composition containing a useful diaryl boron compound is also disclosed, as are particularly preferred diaryl boron compounds.

Benzoxaborole Compounds And Formulations Thereof

View page
US Patent:
20200385409, Dec 10, 2020
Filed:
Nov 30, 2018
Appl. No.:
15/733157
Inventors:
- Durham NC, US
Chun Yu LIU - Durham NC, US
Chunliang LIU - Cary NC, US
Michael SAMUELS - Durham NC, US
Yong-Kang ZHANG - San Jose CA, US
Yasheen ZHOU - Moraga CA, US
International Classification:
C07F 5/02
A01N 55/08
A01N 25/04
A01N 25/08
Abstract:
A benzoxaborole formulation composition including a benzoxaborole, a non-ionic surfactant, or a non-ionic and ionic surfactant mixture, and a carrier is described herein. At least one of the non-ionic surfactant, the non-ionic and ionic surfactant mixture, and the carrier comprise a Lewis base or a N—H or O—H bond. The carrier is a solid or a liquid. Benzoxaborole compounds and methods of using the compounds and formulations of the compounds are described. For example, a method for reducing, preventing, ameliorating, or inhibiting an infestation by a pathogen by applying a compound or a formulation of a compound, wherein the pathogen is selected from insects, nematodes, bacteria, microbes, fungi, protozoa, viruses, and parasites, or any combinations thereof is described.
Control profile
Chun Liu from Carrboro, NC Get Report